MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia. Evans BC, Hocking KM, Osgood MJ, Voskresensky I, Dmowska J, Kilchrist KV, Brophy CM, Duvall CL (2015) Sci Transl Med 7: 291ra95 Heparin-functionalized polymer graft surface eluting MK2 inhibitory peptide to improve hemocompatibility and anti-neointimal activity. Lee Y, Le Thi P, Seon GM, Ryu SB, Brophy CM, Kim Y, Park JC, Park KD, Cheung-Flynn J, Sung HJ (2017) J Control Release 266: 321-330 Role of the small heat shock proteins in regulating vascular smooth muscle tone. McLemore EC, Tessier DJ, Thresher J, Komalavilas P, Brophy CM (2005) J Am Coll Surg 201: 30-6 Transducible recombinant small heat shock-related protein, HSP20, inhibits vasospasm and platelet aggregation. McLemore EC, Tessier DJ, Flynn CR, Furnish EJ, Komalavilas P, Thresher JS, Joshi L, Stone WM, Fowl RJ, Brophy CM (2004) Surgery 136: 573-8 Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. Muto A, Panitch A, Kim N, Park K, Komalavilas P, Brophy CM, Dardik A (2012) Vascul Pharmacol 56: 47-55 Limiting Injury During Saphenous Vein Graft Preparation For Coronary Arterial Bypass Prevents Metabolic Decompensation. Cheung-Flynn J, Song J, Voskresensky I, Wise ES, Liu Y, Xiong Y, Eagle SS, Brophy CM, Flynn CR (2017) Sci Rep 7: 14179 Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury. Hocking KM, Luo W, Li FD, Komalavilas P, Brophy C, Cheung-Flynn J (2016) J Vasc Surg 64: 210-8 Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia. Tessier DJ, Komalavilas P, Liu B, Kent CK, Thresher JS, Dreiza CM, Panitch A, Joshi L, Furnish E, Stone W, Fowl R, Brophy CM (2004) J Vasc Surg 40: 106-14 Detrimental effects of mechanical stretch on smooth muscle function in saphenous veins. Hocking KM, Brophy C, Rizvi SZ, Komalavilas P, Eagle S, Leacche M, Balaguer JM, Cheung-Flynn J (2011) J Vasc Surg 53: 454-60 A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model. Lopes LB, Brophy CM, Flynn CR, Yi Z, Bowen BP, Smoke C, Seal B, Panitch A, Komalavilas P (2010) J Vasc Surg 52: 1596-607 Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein. Osgood MJ, Hocking KM, Voskresensky IV, Li FD, Komalavilas P, Cheung-Flynn J, Brophy CM (2014) J Vasc Surg 60: 202-11 Optimising treatment parameters for Radiofrequency Induced Thermal Therapy (RFiTT): A comparison of the manufacturer's treatment guidance with a locally developed treatment protocol. Newman JE, Meecham L, Walker RJ, Nyamekye IK (2014) Eur J Vasc Endovasc Surg 47: 664-9 Revascularization after segmental resection of lower extremity soft tissue sarcomas. Adelani MA, Holt GE, Dittus RS, Passman MA, Schwartz HS (2007) J Surg Oncol 95: 455-60 P2X7R antagonism after subfailure overstretch injury of blood vessels reverses vasomotor dysfunction and prevents apoptosis. Luo W, Feldman D, McCallister R, Brophy C, Cheung-Flynn J (2017) Purinergic Signal 13: 579-590 Biomechanical stress induces novel arterial intima-enriched genes: implications for vascular adaptation to stress. Pyle AL, Li B, Maupin AB, Guzman RJ, Crimmins DL, Olson S, Atkinson JB, Young PP (2010) Cardiovasc Pathol 19: e13-20 Intimal thickness associated with endothelial dysfunction in human vein grafts. Li FD, Sexton KW, Hocking KM, Osgood MJ, Eagle S, Cheung-Flynn J, Brophy CM, Komalavilas P (2013) J Surg Res 180: e55-62 Blunt traumatic injury to the superior mesenteric artery and celiac axis. Brown DB, Singh H, Atnip RG, Cardella JF, Waybill PN (1998) J Vasc Interv Radiol 9: 783-5 Liposomal entrapment of cefoxitin to improve cellular viability and function in human saphenous veins. Park JC, Suh H, Sung HJ, Han DW, Lee DH, Park BJ, Park YH, Cho BK (2003) Artif Organs 27: 623-30 Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure? Osgood MJ, Harrison DG, Sexton KW, Hocking KM, Voskresensky IV, Komalavilas P, Cheung-Flynn J, Guzman RJ, Brophy CM (2012) Ann Vasc Surg 26: 1130-44 Unregulated saphenous vein graft distension decreases tissue viscoelasticity. Wise ES, Hocking KM, Evans BC, Duvall CL, Cheung-Flynn J, Brophy CM (2017) Perfusion 32: 489-494 Surgical skin markers impair human saphenous vein graft smooth muscle and endothelial function. Eagle S, Brophy CM, Komalavilas P, Hocking K, Putumbaka G, Osgood M, Sexton K, Leacche M, Cheung-Flynn J (2011) Am Surg 77: 922-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.